Concord Medical Services Stock Filter Stocks by Fundamentals
CCM Stock | USD 0.63 0.05 8.62% |
Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.
Concord | Shares Owned by Institutions |
Concord Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 806.0M | 781.1M | 556.7M | 494.1M | 341.0M | 324.0M | |
Enterprise Value | 2.6B | 2.8B | 3.1B | 3.6B | 3.6B | 3.8B |
Concord Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Concord Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Concord Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Concord Medical's value.Shares | Renaissance Technologies Corp | 2023-12-31 | 47.9 K | Rhumbline Advisers | 2023-12-31 | 5.5 K | Blackrock Inc | 2023-12-31 | 143 | Ubs Group Ag | 2023-12-31 | 101 |
Concord Fundamentals
Return On Equity | -0.28 | ||||
Return On Asset | -0.048 | ||||
Profit Margin | (0.55) % | ||||
Operating Margin | (0.98) % | ||||
Current Valuation | 7.19 B | ||||
Shares Outstanding | 43.42 M | ||||
Shares Owned By Insiders | 17.99 % | ||||
Shares Owned By Institutions | 0.10 % | ||||
Number Of Shares Shorted | 6.93 K | ||||
Price To Earning | (3.90) X | ||||
Price To Book | 3.00 X | ||||
Price To Sales | 0.04 X | ||||
Revenue | 537.4 M | ||||
Gross Profit | (152.41 M) | ||||
EBITDA | (313.75 M) | ||||
Net Income | (531.02 M) | ||||
Cash And Equivalents | 157.39 M | ||||
Cash Per Share | 1.72 X | ||||
Total Debt | 3.3 B | ||||
Debt To Equity | 1.25 % | ||||
Current Ratio | 0.71 X | ||||
Book Value Per Share | (48.87) X | ||||
Cash Flow From Operations | (276.47 M) | ||||
Short Ratio | 0.37 X | ||||
Earnings Per Share | (0.94) X | ||||
Target Price | 1.2 | ||||
Number Of Employees | 727 | ||||
Beta | -0.17 | ||||
Market Capitalization | 27.35 M | ||||
Total Asset | 6.05 B | ||||
Retained Earnings | (4.06 B) | ||||
Working Capital | (1.33 B) | ||||
Current Asset | 1.51 B | ||||
Current Liabilities | 1.51 B | ||||
Net Asset | 6.05 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports: Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.